“…A par tial deficiency of MPO has been described in heterozygous subjects [3,4], and in asso ciation with various clinical situations as an apparently acquired form. These include pregnant women [5], neonates [6], infec tious diseases [7,8], Hodgkin's disease and disseminated cancers [9], myeloid metapla sia [10], chronic granulocytic leukemia [11], acute myeloid leukemia [12][13][14][15], preleuke mia [16][17][18][19][20], neuronal lipofuscinosis [21], lead intoxication [22] and during adminis tration of certain drugs [23], The frequency of partial MPO deficiency and the physiol ogic importance of this enzyme has still not been well defined. In the present study, we determined MPO scores of PMNs in various clinical situations and examined if infectious manifestations occur more frequently in partial MPO deficiency.…”